Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and ...

Access Ascendis Pharma AS stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Ascendis Pharma A/S (ASND) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home page ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND) has reported encouraging outcomes from its ongoing Phase 1/2 IL-Believe Trial,... ByInvesting.com • Jun 03, 2024 Ascendis Pharma Presents New Data ...

Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist. The Danish pharma ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Sogroya isn't the only long-acting hGH product on the market as it competes with Pfizer's Ngenla (somatrogon) and Ascendis Pharma's Skytrofa (lonapegsomatropin), which are also dose once-weekly ...